- home
- article
- McKinsey to Pay $650 Million to Settle US Opioid Marketing Case
McKinsey to Pay $650 Million to Settle US Opioid Marketing Case
ai generated text
McKinsey & Company, a prominent consulting firm, has agreed to pay $650 million to settle US criminal charges related to its role in the opioid crisis. The firm collaborated with Purdue Pharma, a pharmaceutical company, to intentionally misbrand opioids, which led to the abuse and over prescription of these highly addictive painkillers. A senior partner at McKinsey was accused of knowingly destroying and hiding records related to the firm's involvement in this scheme. The settlement means that McKinsey will avoid prosecution on criminal charges, but it will still have to pay a significant fine for its role in the opioid crisis.
We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma.
We are deeply sorry for our past client service to Purdue Pharma and the actions of a former partner who deleted documents related to his work for that client.
US Opioid Crisis
- Purdue Pharma Owners Agree to Pay $7.4 Billion in Opioid Settlements
- US Supreme Court Rejects Opioid Settlement Shielding Sackler Family
- Walgreens and CVS offer to pay more than $10 billion to settle opioid lawsuits
sources
perspectives
- 1.Lawsuit
- 2.Healthcare
- 3.Opiods